Results suggest bispecific antibody combination could improve outcomes
Category: News
EMHA calls for its inclusion in EU neurological health strategy
Three-year data highlights inflammation control in psoriatic arthritis
Rheumatology studies show promising results for Sjogren’s disease
Biotech firm to collaborate with NHS on early detection study
Therapy indicated for children aged 3 to 14 at treatment initiation
New funding supports development of diagnostic platform
Treatment provides option for children with growth failure
Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!